8-K: HCA Healthcare Reports Strong Third Quarter Results, Reaffirms 2024 Guidance Despite Hurricane Impacts

HCA Healthcare announced positive third-quarter 2024 results, with revenue reaching $17.487 billion and net income of $1.270 billion, while also reaffirming its 2024 guidance despite the impact of recent hurricanes.

Summary

• HCA Healthcare reported its financial and operating results for the third quarter ended September 30, 2024.
• Revenues for the quarter totaled $17.487 billion, an increase from $16.213 billion in the same quarter of 2023.
• Net income attributable to HCA Healthcare, Inc. was $1.270 billion, or $4.88 per diluted share, compared to $1.079 billion, or $3.91 per diluted share, in the third quarter of 2023.
• Adjusted EBITDA for the quarter was $3.267 billion, up from $2.880 billion in the prior year.
• Same facility admissions and equivalent admissions both increased by 4.5 percent.
• The company experienced an estimated $50 million, or $0.15 per diluted share, unfavorable impact from Hurricane Helene during the third quarter.
• HCA anticipates an additional $200 to $300 million, or $0.60 to $0.90 per diluted share, impact in the fourth quarter due to Hurricanes Helene and Milton.
• The company reaffirmed its 2024 guidance, but expects results to be in the lower half of the provided ranges due to the hurricane impacts.
• Capital expenditures for 2024, excluding acquisitions, are now estimated to be approximately $5 billion.
• The company repurchased 4.948 million shares of its common stock at a cost of $1.795 billion during the third quarter.
• A quarterly cash dividend of $0.66 per share was declared, payable on December 27, 2024, to shareholders of record on December 13, 2024.

Sentiment

Score: 7

Explanation: The sentiment is positive due to strong financial results and reaffirmed guidance, but tempered by the negative impact of hurricanes and the expectation of lower results within the guidance range. The initial 2025 outlook is also a positive factor.

Positives

• HCA Healthcare experienced a significant increase in revenue, reaching $17.487 billion in the third quarter of 2024.
• Net income attributable to HCA Healthcare, Inc. increased to $1.270 billion, or $4.88 per diluted share.
• Adjusted EBITDA saw a substantial rise to $3.267 billion.
• Same facility admissions and equivalent admissions both grew by 4.5 percent.
• Cash flows from operating activities were robust at $3.515 billion.
• The company successfully repurchased 4.948 million shares of its common stock.
• HCA declared a quarterly cash dividend of $0.66 per share.
• The company's initial 2025 outlook suggests diluted earnings per share and Adjusted EBITDA growth to be near, or slightly above, the upper end of its long-term growth ranges.

Negatives

• The company experienced an estimated $50 million, or $0.15 per diluted share, unfavorable impact from Hurricane Helene in the third quarter.
• HCA anticipates an additional $200 to $300 million, or $0.60 to $0.90 per diluted share, impact in the fourth quarter due to Hurricanes Helene and Milton.
• The company expects 2024 results to be in the lower half of the provided guidance ranges due to the hurricane impacts.
• Same facility outpatient surgeries declined by 2.0 percent in the third quarter of 2024 compared to the same period of 2023.

Risks

• The company faces ongoing financial impacts from Hurricanes Helene and Milton, estimated to be between $200 to $300 million in the fourth quarter.
• The company's 2024 guidance is subject to various uncertainties, including economic conditions, inflation, and the ongoing impacts of the hurricanes.
• The company's future performance is subject to a number of known and unknown uncertainties and risks, including changes in economic conditions, healthcare regulations, and competition.
• There are risks associated with the company's significant indebtedness and the ability to refinance it on acceptable terms.
• The company is exposed to potential cybersecurity incidents and data breaches.

Future Outlook

The company reaffirmed its 2024 guidance but expects results to be in the lower half of the provided ranges due to the impact of recent hurricanes. The company anticipates some ongoing impact in 2025 from Hurricane Helene on its North Carolina facilities, but believes these ongoing effects will be manageable and currently expects 2025 diluted earnings per share and Adjusted EBITDA growth to be near, or slightly above, the upper end of its long-term growth ranges.

Management Comments

• Sam Hazen, Chief Executive Officer of HCA Healthcare, expressed gratitude for the dedication and bravery of the company's people during the recent hurricanes.
• Management stated that they believe the ongoing effects of Hurricane Helene will be manageable in 2025.

Industry Context

HCA Healthcare's results reflect the ongoing demand for healthcare services, with increased admissions and revenue. The impact of the hurricanes highlights the vulnerability of healthcare providers to natural disasters. The company's reaffirmation of its 2024 guidance, despite these challenges, indicates confidence in its underlying business model. The company's initial 2025 outlook suggests a positive trajectory for the coming year.

Comparison to Industry Standards

• HCA Healthcare's revenue growth of approximately 7.8% year-over-year in Q3 2024 is strong compared to some of its peers in the hospital management sector, such as Tenet Healthcare which has seen more modest growth in recent quarters.
• The adjusted EBITDA margin of 18.7% for HCA in Q3 2024 is competitive with other large for-profit hospital chains, though some may have slightly higher or lower margins depending on their specific market mix and cost structures.
• HCA's same-facility admission growth of 4.5% is a positive indicator of organic growth, and is in line with or slightly above the industry average for large hospital systems.
• The impact of hurricanes on HCA's Q3 and Q4 results is a unique factor, and while other healthcare providers in affected regions may have experienced similar challenges, the scale of HCA's operations means the financial impact is more significant.
• HCA's share repurchase program is a common practice among large healthcare companies, and the $1.795 billion spent in Q3 is a substantial amount, indicating a commitment to returning value to shareholders.
• The company's dividend yield is in line with other large healthcare companies, and the increase in the dividend is a positive sign for investors.

Stakeholder Impact

• Shareholders will benefit from the increased dividend and share repurchase program.
• Employees are recognized for their dedication and bravery during the hurricanes.
• Customers may experience some disruptions in service due to the hurricane impacts.
• Suppliers may see some changes in demand due to the hurricane impacts.

Next Steps

• The company will host an earnings conference call for investors.
• The company will continue to monitor and manage the ongoing impacts of Hurricanes Helene and Milton.
• The company will complete its 2025 planning process.

Key Dates

Keywords

HCA Healthcare, Healthcare, Hospital, Financial Results, Quarterly Report, EBITDA, Revenue, Net Income, Admissions, Hurricane Impact, Dividends, Share Repurchase